Cargando…

Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer

BACKGROUND: Complete pathological response occurs in 10–20% of patients with rectal cancer who are treated with neoadjuvant chemoradiation therapy prior to pelvic surgery. The possibility that complete pathological response of rectal cancer can also occur with neoadjuvant chemotherapy alone (without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naiken, Surennaidoo P, Toso, Christian, Rubbia-Brandt, Laura, Thomopoulos, Theodoros, Roth, Arnaud, Mentha, Gilles, Morel, Philippe, Gervaz, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900671/ https://www.ncbi.nlm.nih.gov/pubmed/24438090 http://dx.doi.org/10.1186/1471-2482-14-4

Ejemplares similares

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Is adjuvant chemotherapy necessary for patients with ypT0–2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
por: Lu, Zhao, et al.
Publicado: (2018)

Multiple brain metastases in a patient with ypT0N0 micropapillary urothelial carcinoma of the bladder
por: Kuppa, Srikar, et al.
Publicado: (2021)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
por: Galata, Christian, et al.
Publicado: (2018)

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer
por: Wan, Jue-feng, et al.
Publicado: (2015)

Oncologic effects of adjuvant chemotherapy in patients with ypT0–2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis
por: Ha, Gi Won, et al.
Publicado: (2020)

Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
por: Su, Pengfei, et al.
Publicado: (2022)

Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy
por: Shao, Xinxin, et al.
Publicado: (2023)

Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis
por: Jung, Sung Min, et al.
Publicado: (2016)

Predicting stage ypT0–1N0 for nonradical management in patients with middle or low rectal cancer who undergo neoadjuvant chemoradiotherapy: a retrospective cohort study
por: Lee, Jeehye, et al.
Publicado: (2022)

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis
por: Kuo, Yu-Hsuan, et al.
Publicado: (2022)

Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
por: Oh, Soo Young, et al.
Publicado: (2021)

ypT0 gastric carcinoma after preoperative chemotherapy: a unique status according to AJCC 8(th) edition cancer staging system
por: Zhu, Kankai, et al.
Publicado: (2020)

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
por: Trotsyuk, Iryna, et al.
Publicado: (2019)

A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?
por: Celik, Sebahattin, et al.
Publicado: (2015)

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
por: You, Kai-yun, et al.
Publicado: (2014)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
por: Kong, Min, et al.
Publicado: (2020)

The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2017)

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2019)

Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study
por: Peltrini, Roberto, et al.
Publicado: (2022)

Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2022)

PATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
por: ANDREOLLO, Nelson Adami, et al.
Publicado: (2018)

Management of a complex pancreaticoduodenal lesion following a suicidal attempt with a crossbow
por: Benmohamed, Nadja, et al.
Publicado: (2016)

Rectal gastrointestinal stromal tumour: What do we know in 2017? A systematic review protocol
por: Naiken, Surennaidoo, et al.
Publicado: (2017)

The prognostic differences and the effect of postmastectomy radiotherapy between post‐chemotherapy ypT1‐2ypN1 and de novo pT1‐2N1 breast cancer
por: Yang, Tian, et al.
Publicado: (2023)

Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients
por: Cho, Min Soo, et al.
Publicado: (2019)

Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes
por: Chen, Nan, et al.
Publicado: (2019)

The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2021)

Stratified Prognostic Value of Pathological Response to Preoperative Treatment in yp II/III Rectal Cancer
por: Yang, Yanpeng, et al.
Publicado: (2021)

The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019)

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
por: Wang, Ke, et al.
Publicado: (2021)

The Z$^{0}$
por: Rubbia, Carlo, et al.
Publicado: (1990)

Reducing anastomotic leak in colorectal surgery: The old dogmas and the new challenges
por: Meyer, Jeremy, et al.
Publicado: (2019)

Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer
por: Shin, Young Seob, et al.
Publicado: (2016)

Efficacy of preoperative chemoradiotherapy in patients with cT2N0 distal rectal cancer
por: Park, Min Young, et al.
Publicado: (2023)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy
por: Wasserberg, Nir, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nevsr5f6du1aqa04detf4l0r1h